TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It October 22, 1982